|
16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid |
|
CHEBI:140264 |
|
16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid |
|
A docosanoid that is 17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid in which a glycinyl group is attached at position 16S via a sulfide linkage. An intermediate of specialised proresolving mediators |
|
This entity has been manually annotated by the ChEBI Team.
|
|
Bijay
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C25H37NO5S/c1-2-3-14-17-22(27)23(32-20-21(26)25(30)31)18-15-12-10-8-6-4-5-7-9-11-13-16-19-24(28)29/h3,5-8,10-15,18,21-23,27H,2,4,9,16-17,19-20,26H2,1H3,(H,28,29)(H,30,31)/b7-5-,8-6?,12-10?,13-11-,14-3-,18-15?/t21-,22+,23-/m0/s1 |
GFHRZNBJDWPKHL-XUVPQBAGSA-N |
C(\CC=CC=CC=C[C@@H]([C@@H](C/C=C\CC)O)SC[C@H](N)C(O)=O)=C\C/C=C\CCC(O)=O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
|
|
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
|
|
View more via ChEBI Ontology
Outgoing
|
16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid
(CHEBI:140264)
has role
human xenobiotic metabolite
(CHEBI:76967)
16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid
(CHEBI:140264)
has role
specialised pro-resolving mediator
(CHEBI:140399)
16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid
(CHEBI:140264)
is a
S-substituted L-cysteine
(CHEBI:47910)
16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid
(CHEBI:140264)
is a
dicarboxylic acid
(CHEBI:35692)
16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid
(CHEBI:140264)
is a
docosanoid
(CHEBI:131863)
16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid
(CHEBI:140264)
is a
organic sulfide
(CHEBI:16385)
16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid
(CHEBI:140264)
is a
secondary alcohol
(CHEBI:35681)
16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid
(CHEBI:140264)
is conjugate acid of
16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(1−)
(CHEBI:140401)
|
|
Incoming
|
16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(1−)
(CHEBI:140401)
is conjugate base of
16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid
(CHEBI:140264)
|
(4Z,7Z,16S,17R,19Z)-16-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-17-hydroxydocosa-4,7,10,12,14,19-hexaenoic acid
|
16-cysteinyl,17-hydroxy-4Z,7Z,16S,17R,19Z-docosahexaenoic acid
|
ChEBI
|
PCTR3
|
SUBMITTER
|
protectin conjugate in tissue regeneration 3
|
SUBMITTER
|
25713027
|
PubMed citation
|
Europe PMC
|
|